Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Financials Score | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC | $185.24M | -52.00% | 11.20% | 12.43% | 23.30% | 21.96 | 6.93 | 96.20% | 8.30% | 16.42% | |
| TGTX | TG THERAPEUTICS INC | $2.52B | 31.30% | 13.10% | 19.62% | 21.90% | 1.33 | 3.62 | 93.50% | 14.20% | 18.55% | |
| SRPT | SAREPTA THERAPEUTICS INC | $12.27B | 2.00% | 0.50% | 1.30% | 1.00% | 2.36 | 4.05 | 88.20% | 1.20% | 2.43% | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.67B | 28.30% | 17.20% | 30.75% | 53.30% | 0.64 | 3.11 | 79.30% | 22.30% | 34.50% | |
| INCY | INCYTE CORP | $12.98B | 14.70% | 11.20% | 17.79% | 53.00% | 0.32 | 3.47 | 93.10% | 19.80% | 27.10% | |
| CORT | CORCEPT THERAPEUTICS INC | $3.14B | 24.20% | 19.60% | 21.67% | 34.30% | 0.20 | 5.18 | 98.50% | 22.40% | 23.13% | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.91B | 15.60% | 13.20% | 15.22% | 137.20% | 0.15 | 5.09 | 86.70% | 15.80% | 20.98% | |
| HALO | HALOZYME THERAPEUTICS INC | $5.64B | 192.70% | 17.50% | 24.03% | 19.50% | 9.36 | 6.64 | 78.50% | 36.90% | 47.61% | |
| RPRX | ROYALTY PHARMA PLC | $16.38B | 8.10% | 4.90% | 6.14% | 4.60% | 0.64 | 12.52 | 100.00% | 35.70% | 43.93% | |
| GMAB | GENMAB A | $18.65B | 17.60% | 15.70% | 23.76% | 41.70% | 0.13 | 12.46 | 97.70% | 30.70% | 45.37% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $14.25B | 4.20% | 3.00% | 4.40% | 4.50% | 0.36 | 2.74 | 79.20% | 8.30% | 10.30% | |
| MNKD | MANNKIND CORP | $1.27B | -3.40% | 2.10% | 10.37% | 6.70% | -3.09 | 3.84 | 71.00% | 3.80% | 17.60% | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.63B | 9.20% | 2.90% | 5.32% | 7.30% | 2.06 | 2.27 | 89.50% | 8.60% | 13.51% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $185.72M | 35.40% | 7.20% | 25.79% | 28.50% | 3.20 | 1.46 | 73.40% | 6.80% | 13.20% | |
| TECH | BIO-TECHNE CORP | $12.16B | 10.20% | 7.50% | 9.47% | 16.90% | 0.35 | 4.08 | 66.80% | 17.60% | 21.10% | |
| BNTX | BIONTECH SE | $23.92B | 0.60% | 0.50% | 0.87% | 2.20% | 0.12 | 11.38 | 79.40% | 4.10% | 6.59% | |
| EXEL | EXELIXIS INC | $6.32B | 8.90% | 6.90% | 10.64% | 10.90% | 0.32 | 3.47 | 95.70% | 11.10% | 14.00% | |
| MDXG | MIMEDX GROUP INC | $1.06B | 103.30% | 35.90% | 25.77% | 43.20% | 0.42 | 3.29 | 83.50% | 22.20% | 13.82% | |
| REGN | REGENERON PHARMACEUTICALS INC | $108.00B | 15.10% | 11.80% | 13.36% | 14.40% | 0.27 | 5.27 | 86.30% | 29.40% | 31.40% | |
| UTHR | UNITED THERAPEUTICS CORP | $12.20B | 18.70% | 15.40% | 25.55% | 25.60% | 0.22 | 3.78 | 88.90% | 42.00% | 57.63% | |
| NVO | NOVO NORDISK A S | $610.11B | 91.80% | 29.90% | 84.19% | 133.20% | 2.02 | 0.70 | 84.60% | 36.60% | 45.95% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.